Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
611.84B | 619.51B | 578.91B | 559.24B | 510.44B | 452.04B | Gross Profit |
171.71B | 174.78B | 155.85B | 153.78B | 162.69B | 122.98B | EBIT |
77.71B | 80.05B | 65.61B | 66.76B | 83.53B | 50.82B | EBITDA |
100.27B | 133.62B | 117.00B | 119.75B | 132.80B | 95.77B | Net Income Common Stockholders |
47.69B | 54.93B | 40.56B | 55.05B | 70.85B | 38.50B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
272.40B | 263.87B | 242.67B | 214.71B | 185.64B | 166.36B | Total Assets |
1.15T | 1.14T | 1.13T | 1.03T | 982.83B | 908.97B | Total Debt |
274.73B | 252.24B | 259.32B | 253.36B | 252.35B | 264.24B | Net Debt |
69.23B | 54.27B | 66.67B | 84.91B | 113.15B | 132.88B | Total Liabilities |
427.80B | 415.48B | 424.35B | 386.72B | 393.24B | 391.07B | Stockholders Equity |
718.36B | 720.58B | 696.28B | 636.33B | 584.09B | 512.88B |
Cash Flow | Free Cash Flow | ||||
0.00 | 54.86B | 54.02B | 54.80B | 57.40B | 32.30B | Operating Cash Flow |
0.00 | 96.66B | 99.16B | 97.95B | 94.83B | 85.64B | Investing Cash Flow |
0.00 | -55.08B | -68.59B | -52.01B | -46.29B | -51.72B | Financing Cash Flow |
0.00 | -34.22B | -36.12B | -34.57B | -45.26B | 12.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥679.08B | 16.33 | 2.04% | 3.24% | 36.34% | ||
76 Outperform | $495.32B | 9.38 | 7.66% | 2.93% | 7.01% | 39.29% | |
76 Outperform | ¥140.37B | 12.49 | 2.68% | 20.05% | -26.75% | ||
68 Neutral | ¥475.07B | 53.90 | 2.48% | 6.63% | 2.63% | -34.53% | |
66 Neutral | $4.47B | 12.21 | 5.40% | 3.65% | 4.14% | -12.00% | |
64 Neutral | ¥568.67B | 31.66 | 9.67% | 0.98% | -1.56% | 25.78% |